CD8A and non-small cell lung carcinoma: Our findings that PD-1 antibody activates CD8 T cells in the en bloc NSCLC culture made us wonder whether en bloc NSCLC could be employed to evaluate the tumoricidal efficacy of PD-1 antibody against NSCLC ex vivo.